Kytopen

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a cell engineering platform designed to offer healthy and functional cells. Kytopen is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $47 million in Sep 2024. It has raised $52.9 million across 5 recorded rounds; the latest was a $7.1 million early-stage round in Feb 2025.

Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$52.9M
Last round
Early Stage VC
Feb 2025

Who backs Kytopen?

16 investors
InvestorType
US National Science FoundationOther
National Institutes of HealthOther
Alexandria Venture InvestmentsOther
The EngineOther
MassVenturesOther
Bantam GroupAngel
Horizons VenturesVenture capital
Engine VenturesVenture capital
Joe Caruso—
John Ballantyne—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kytopen investors

16 investors are on record for Kytopen, including US National Science Foundation, National Institutes of Health, Alexandria Venture Investments and The Engine. The early-stage round in Feb 2025 drew 13 investors.

Free account
More of Kytopen with a free account
  • ·The complete investor list: 16 names
  • ·Watch Kytopen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Kytopen. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View